Wednesday's big stock stories: What’s likely to move the market in the next trading session

Berkshire Hathaway's A and B shares touched fresh highs Tuesday and are up almost 11% over the past month. Ahead of Wednesday earnings, McDonald's, CVS Health, Kraft Heinz and Uber have declined over the cited periods, while Qualcomm is up 8.5% in three months and Arm is down 15%. CrowdStrike CEO George Kurtz described a new AI-agent “kill switch” unveiled at a Barcelona conference; CrowdStrike shares rose 1.2% Tuesday.

Analysis

The investable signal is the potential shift from AI-agent access controls being a feature to becoming a procurement or insurance requirement. If customers pay for the control layer, CrowdStrike could deepen platform retention; if it is bundled by Microsoft or Palo Alto Networks, it may instead defend renewals without supporting incremental pricing. Insurance-driven adoption remains a hypothesis, not established demand. A poorly governed shutdown could also interrupt business-critical workflows and create liability rather than reduce it.

Over the next days, the scheduled earnings slate is an event-risk cluster, not a directional signal: without estimates, guidance expectations, or business-level data, recent share-price weakness alone does not establish either a bargain or deteriorating fundamentals. Over 1–3 months, watch for explicit agent-control bookings, attach rates, pricing, and insurer requirements. Over 6–18 months, the key question is whether control standards become a durable paid layer or a commoditized checkbox.

Berkshire’s strong run may reflect a quality/defensive rotation, but it raises near-term reversal risk if that positioning unwinds; this is not enough to infer a change in intrinsic value. The sharp relative moves in Arm and Qualcomm likewise do not establish a valuation opportunity without updated demand, guidance, and expectations. Falsify the CrowdStrike adoption thesis if management reports weak uptake or no monetization, or if competitors bundle comparable controls and pricing fails to hold.

Key Decisions for Investors

• Treat CRWD as a catalyst watch, not a buy on the product announcement alone. Reassess after evidence of paid attach, customer adoption, or insurer requirements; compare bundling and pricing from Microsoft and Palo Alto Networks.
• For CRWD exposure, define downside around evidence that the feature is included at no incremental price, weak adoption, or control failures that disrupt customers. A relative-value position versus other cybersecurity names needs valuation and growth data not supplied here.
• Avoid initiating directional positions in MCD, CVS, KHC, or UBER solely on their recent drawdowns ahead of earnings. Verify consensus expectations and segment-level guidance first; a material guide change, not the price chart, is the catalyst.
• Do not chase BRK.A’s momentum or fade it solely on the run-up. Monitor whether the move persists alongside broader defensive-factor flows; reversal in those flows would be the near-term risk.